166 related articles for article (PubMed ID: 29064087)
1. Sentinel lymph node biopsy status is not the most powerful predictor of prognosis in cutaneous melanoma.
Zagarella S; Lee S; Heenan P
Australas J Dermatol; 2017 Nov; 58(4):256-258. PubMed ID: 29064087
[TBL] [Abstract][Full Text] [Related]
2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
3. Exhaustive pathologic work-up in sentinel lymph node biopsy for melanoma: is it necessary?
Lino-Silva LS; Castillo-Medina AL; Salcedo-Hernández RA; García-Pérez L
Melanoma Res; 2017 Apr; 27(2):116-120. PubMed ID: 28030434
[TBL] [Abstract][Full Text] [Related]
4. When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'.
Gyorki DE; Barbour A; Hanikeri M; Mar V; Sandhu S; Thompson JF
Australas J Dermatol; 2017 Nov; 58(4):274-277. PubMed ID: 28718222
[TBL] [Abstract][Full Text] [Related]
5. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
7. Counterpoint: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma.
Ross MI
Oncology (Williston Park); 2016 Oct; 30(10):891, 893-5. PubMed ID: 27753055
[No Abstract] [Full Text] [Related]
8. Point: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma.
Sarnaik AA; Zager JS; Sondak VK
Oncology (Williston Park); 2016 Oct; 30(10):891-2, 895. PubMed ID: 27753054
[No Abstract] [Full Text] [Related]
9. Proposal for the applicability of modified Breslow (measured from the basal membrane) as a predictor of survival and sentinel lymph node outcome in patients with cutaneous melanoma.
Asato MA; Moares Neto FA; Moraes MPT; Ocanha-Xavier JP; Takita LC; Marques MEA; Xavier-Júnior JCC
An Bras Dermatol; 2024; 99(3):398-406. PubMed ID: 38378363
[TBL] [Abstract][Full Text] [Related]
10. Multiple Lymph Node Basin Drainage in Trunk Melanoma Is Not Associated with Survival of Sentinel Lymph Node-Positive Patients.
Ribero S; Osella Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P;
Dermatology; 2017; 233(2-3):205-211. PubMed ID: 28738392
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
[TBL] [Abstract][Full Text] [Related]
12. Regression and Sentinel Lymph Node Status in Melanoma Progression.
Letca AF; Ungureanu L; Şenilă SC; Grigore LE; Pop Ş; Fechete O; Vesa ŞC; Cosgarea R
Med Sci Monit; 2018 Mar; 24():1359-1365. PubMed ID: 29507279
[TBL] [Abstract][Full Text] [Related]
13. Time to reconsider the role of sentinel lymph node biopsy in melanoma.
Bigby M; Zagarella S; Sladden M; Popescu CM
J Am Acad Dermatol; 2019 Apr; 80(4):1168-1171. PubMed ID: 30471314
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
Hao H; Xiao D; Pan J; Qu J; Egger M; Waigel S; Sanders MA; Zacharias W; Rai SN; McMasters KM
Ann Surg Oncol; 2017 Jan; 24(1):108-116. PubMed ID: 27663566
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
17. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node status affects long-term survival in patients with intermediate-thickness melanoma.
G Lben K; Berberoğlu U; Altınyollar H; Kınaş V; Turanlı S
J Cancer Res Ther; 2016; 12(2):840-4. PubMed ID: 27461661
[TBL] [Abstract][Full Text] [Related]
19. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
Kruit WH;
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
[TBL] [Abstract][Full Text] [Related]
20. Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
Munsch C; Lauwers-Cances V; Lamant L; Gentil C; Rochaix P; Garrido I; Lopez R; Chevreau C; Paul C; Meyer N
Dermatology; 2014; 229(3):183-9. PubMed ID: 25171688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
